1. World Health Organization. Global tuberculosis report 2012. Geneva: WHO; 2012.
2. European Centre for Disease Prevention and Control (ECDC)/World Health Organization (WHO) Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe, 2013. Stockholm: ECDC;2013.
3. Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, et al. Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J. 2000;16(2):364-71.
4. Kodmon C, Hollo V, Huitric E, Amato-Gauci A, Manissero D. Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area. Euro Surveill. 2010;15(11). pii: 19519.
5. Perdigão J, Macedo R, Silva C, Pinto C, Furtado C, Brum L, et al. Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview. Clin Microbiol Infect. 2011;17(9):1397-402.